SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-051012
Filing Date
2019-09-27
Accepted
2019-09-27 16:34:10
Documents
2
Period of Report
2019-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1615
2 POA DOCUMENT poa.txt EX-24.3_873827 4194
  Complete submission text file 0001209191-19-051012.txt   7294
Mailing Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE SUITE 3000N LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Issuer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MERRIMACK PHARMACEUTICALS, INC. ONE KENDALL SQUARE, SUITE B7201 CAMBRIDGE MA 02139
Business Address
Munsie Jeffrey A (Reporting) CIK: 0001703041 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36310 | Film No.: 191122479